跳至主要内容
临床试验/EUCTR2016-001223-31-GB
EUCTR2016-001223-31-GB进行中(未招募)1 期

Incidence of Invasive Fungal Disease in Patients receiving Immunosuppressive Therapy, Intensive Chemotherapy or Reduced Intensity Haematopoietic Stem Cell Transplantation on Posaconazole Prophylaxis - King's Invasive Aspergillosis Study II (KIASII)

King's College Hospital NHS Foundation Trust0 个研究点目标入组 150 人开始时间: 2016年9月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Adult > or = to 18 years
  • 2. Patients with aplastic anaemia, MDS or AML undergoing: IST; or Intensive chemotherapy such as induction chemotherapy; or RIC allogeneic HSCT
  • 3. Able to swallow and retain orally administered medication
  • 4.Patients must agree to use and apply with effective contraception without interruption throughout the duration of study drug therapy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 150
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 150

排除标准

  • 1. Refusal or inability to consent
  • 2. Autologous HSCT
  • 3. Contraindicated medications
  • 4. Current evidence of IFD diagnosis or treatment
  • 5.Women who are pregnant or lactating

研究者

相似试验

已完成
4 期
King's invasive aspergillosis study II (KIASII)Specialty: Haematology, Primary sub-specialty: HaematologyUKCRC code/ Disease: Infection/ Other bacterial diseasesInfections and InfestationsInvasive fungal disease
ISRCTN11847553King's College Hospital NHS Foundation Trust120
招募中
不适用
Impact of antifungal prophylaxis. A prospective, multicenter, observational study in India (MISFIC)
CTRI/2014/04/004544MSD PHARMA200
招募中
不适用
Incidence and outcome of invasive fungal infections in pediatric patients with hematological malignancies and/or undergoing allogeneic hematopoietic stem cell transplantation – a prospective analysis in three major pediatric cancer centers (IFI-PED Study)”Children with hematological malignancy (C91.0C92.0)/children undergoing hematopoietic stem cell transplantationproven, probable, and possible invasive fungal infection (B49)B49C92.0C91.0Unspecified mycosisAcute myeloblastic leukaemia [AML]Acute lymphoblastic leukaemia [ALL]
DRKS00006341Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität500
招募中
不适用
Oucome of resection of invasive fungal disease of the lung in pediatric hemato-oncological patientsProven/probable invasive fungal diseases (IFD) of the lung according to definition of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSGERC).
DRKS00024719niversitätsklinikum Freiburg, Klinik für Thoraxchirurgie120
招募中
不适用
Incidence of parasitic infection in patients with hypereosinophiliaThe patient 18 years and older who were diagnosed with more eosinophils 1,500/cu.mm.Incidence of parasitic infection in patients with hypereosinophilia. The patient 18 years and older who were diagnosed with more eosinophils 1,500/cu.mm.
TCTR20211129002Siriraj Hospital Mahidol University120